The combined Annual Scientific Meeting of the:
Carl de Gruchy Orator
Head of Haematology Department, Flinders Medical Centre
Supported by Amgen
Mt. Sinai Cancer Clinical Trials Office, New York, USA
Supported by Astra Zeneca
Mayo Clinic, Florida, USA
Department of Internal Medicine, University Hospital of Ulm, Germany
Perelman School of Medicine, University of Pennsylvania, USA
Supported by BMS
Translational Genomics Research Institute (TGen), City of Hope Cancer Center, USA
Supported by Janssen
Department of Hematology, Hospital de Sant Pau i Santa Creu, Spain
Supported by Gilead
Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, USA
Supported by Abbvie
University of Colorado School of Medicine, USA
Ruth Sanger Orator
Manager, Blood Matters Program, VIC
Toronto General Hospital Research Institute, Toronto, Canada
Grifols Laboratory Services, Texas, USA
Transfusion Medicine, NHS Blood and Transplant, Birmingham, UK
Barry Firkin Orator
Department of Medicine, McMaster University, Canada
Division of Hematology, The Ottawa Hospital, Canada
French National Institute of Health and Medical Research (INSERM), France
Consultant Haematologist, University College London Hospital, UK
RCNi Nursing Management, Belfast, Northern Ireland
